Back
Reshape Lifesciences Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
RSLS
Reshape Lifesciences
Last Price:
$2.93
Seasonality Move:
-30.46%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and RSLS is experiencing slight buying pressure.
Reshape Lifesciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.53 | Buy |
| 20-day SMA: | 2.51 | Buy |
| 50-day SMA: | 4.25 | Sell |
| 200-day SMA: | 64.6 | Sell |
| 8-day EMA: | 2.57 | Buy |
| 20-day EMA: | 2.77 | Buy |
| 50-day EMA: | 6.13 | Sell |
| 200-day EMA: | 187.01 | Sell |
Reshape Lifesciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.49 | Sell |
| Relative Strength Index (14 RSI): | 45.28 | Sell |
| Chaikin Money Flow: | 155269 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.35 - 2.71) | Buy |
| Bollinger Bands (100): | (1.9 - 18.12) | Sell |
Reshape Lifesciences Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Reshape Lifesciences Stock
Is Reshape Lifesciences Stock a Buy?
-
Reshape Lifesciences share price is 2.83 while RSLS 8-day simple moving average is 2.53, which is a Buy signal.
-
The stock price of RSLS is 2.83 while Reshape Lifesciences 20-day SMA is 2.51, which makes it a Buy.
-
Reshape Lifesciences 50-day simple moving average is 4.25 while RSLS share price is 2.83, making it a Sell technically.
-
RSLS stock price is 2.83 and Reshape Lifesciences 200-day simple moving average is 64.60, creating a Sell signal.
RSLS Technical Analysis vs Fundamental Analysis
Sell
33
Reshape Lifesciences (RSLS)
is a Sell
Is Reshape Lifesciences a Buy or a Sell?
-
Reshape Lifesciences stock is rated a SellThe current Reshape Lifesciences [RSLS] share price is $2.83. The Score for RSLS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Reshape Lifesciences Stock Info
Market Cap:
2.1M
Price in USD:
2.83
Share Volume:
520.3K
Reshape Lifesciences 52-Week Range
52-Week High:
347.86
52-Week Low:
2.23
Sell
33
Reshape Lifesciences (RSLS)
is a Sell
Reshape Lifesciences Share Price Forecast
-
What is the Reshape Lifesciences stock price today?The Reshape Lifesciences stock price is 2.83 USD today.
-
Will RSLS stock go up or go down?Reshape Lifesciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Reshape Lifesciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reshape Lifesciences is overvalued.
Is Reshape Lifesciences Stock a Buy?
-
Reshape Lifesciences share price is 2.83 while RSLS 8-day exponential moving average is 2.57, which is a Buy signal.
-
The stock price of RSLS is 2.83 while Reshape Lifesciences 20-day EMA is 2.77, which makes it a Buy.
-
Reshape Lifesciences 50-day exponential moving average is 6.13 while RSLS share price is 2.83, making it a Sell technically.
-
RSLS stock price is 2.83 and Reshape Lifesciences 200-day simple moving average is 187.01, creating a Sell signal.
Fundamental Analysis of Reshape Lifesciences
Is Reshape Lifesciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Reshape Lifesciences
Should I short Reshape Lifesciences stock?
-
RSLS Moving Average Covergence Divergence (MACD) indicator is -0.49, suggesting Reshape Lifesciences is a Sell
-
Reshape Lifesciences Relative Strength Index (RSI) is 45.28, which suggest Reshape Lifesciences is oversold
-
The Bollinger Bands (25) for Reshape Lifesciences is (2.35 - 2.71), which suggest Reshape Lifesciences is a Sell
-
The Bollinger Bands (100) for Reshape Lifesciences is (1.9 - 18.12), which suggest Reshape Lifesciences is a Sell
* Reshape Lifesciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.